Ovarian cancer: emerging molecular-targeted therapies
Carole SourbierRockville, MD, USAAbstract: With about 22,000 new cases estimated in 2012 in the US and 15,500 related deaths, ovarian cancer is a heterogeneous and aggressive disease. Even though most of patients are sensitive to chemotherapy treatment following surgery, recurring disease is almost...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-06-01
|
| Series: | Biologics : Targets & Therapy |
| Online Access: | http://www.dovepress.com/ovarian-cancer-emerging-molecular-targeted-therapies-a10178 |